MedMira30. Apr.2 Min.MedMira Announces the Hire of Vice President of Business DevelopmentHalifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their...
MedMira19. Apr.1 Min.Innovation made easyWith MedMira's patented RVF Technology, there are a myriad of possibilities: As an example, our latest custom made product for one of our...
MedMira13. März4 Min.MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic SystemHalifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent...
MedMira1. Feb.3 Min.Corporate Update on Clinical Evaluation of MedMira’s ProductsHalifax, Nova Scotia,1 February, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to provide an update on the ongoing review...
MedMira14. Dez. 20233 Min.U.S. FDA Approves MedMira’s Advanced Reveal® G4 Rapid HIV-1/2 Antibody TestHalifax, Nova Scotia, 13 December, 2023 – Today, MedMira Inc. (MedMira) (TSXV: MIR) MedMira Inc. proudly announces today the successful...
MedMira29. Nov. 20232 Min.FY 2023 UpdateCorporate Update Throughout the reporting period, the Company achieved significant milestones in its pursuit of FDA and Health Canada...